ChemicalBook >> CAS DataBase List >>Elotuzumab

Elotuzumab

Elotuzumab structure

CAS No.: 915296-00-3

Chemical Name:: Elotuzumab

Synonyms: Elotuzumab;Elotuzumab (anti-SLAMF7);Research Grade Elotuzumab;Research Grade Elotuzumab(DHJ64001);Elotuzumab (anti-SLAMF7)|||BMS 901608|||PDL 063|||HuLuc 63

CBNumber:: CB78080795

Molecular Formula:

Molecular Weight:: 0

MDL Number:

MOL File:: Mol file

MSDS File:: SDS

TDS File:: TDS

Last updated:2026-04-24 14:58:40

Request For Quotation

Elotuzumab Properties

storage temp.	Store at -20°C
form	Liquid
color	Colorless to light yellow
FDA UNII	1351PE5UGS
NCI Drug Dictionary	elotuzumab
ATC code	L01XC23

Elotuzumab price

Manufacturer	Product number	Product description	CAS number	Packaging	Price	Updated	Buy
Biosynth	CLA1036	Elotuzumab	915296-00-3	1mg	$1375	2026-06-04	Buy
Biosynth	CLA1036	Elotuzumab	915296-00-3	5mg	$2406.25	2026-06-04	Buy
Biosynth	CLA1036	Elotuzumab	915296-00-3	10mg	$4042.5	2026-06-04	Buy
ChemScene	CS-0030908	Elotuzumab 99.9%	915296-00-3	1mg	$303	2026-06-04	Buy
ChemScene	CS-0030908	Elotuzumab 99.9%	915296-00-3	5mg	$921	2026-06-04	Buy

Product number	Packaging	Price	Buy
CLA1036	1mg	$1375	Buy
CLA1036	5mg	$2406.25	Buy
CLA1036	10mg	$4042.5	Buy
CS-0030908	1mg	$303	Buy
CS-0030908	5mg	$921	Buy

Elotuzumab Chemical Properties,Uses,Production

Uses

Elotuzumab is a monoclonal antibody directed against the SLAMF7 receptor. Elotuzumab has no significant antimyeloma activity when given as a single agent with relapsed or refractory multiple myeloma (RRMM). Elotuzumab results in improved response and outcome when combined with other antimyeloma agents[1].

References

[1] Magen H, et al. Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment. Ther Adv Hematol. 2016;7(4):187-195.

Elotuzumab Preparation Products And Raw materials

Raw materials

Preparation Products

Elotuzumab Suppliers

Global( 32)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
Bide Pharmatech Ltd.	400-164-7117 18317119277	product02@bidepharm.com	China	40000	60
Shanghai YuanYe Biotechnology Co., Ltd.	15026964105	2881489226@qq.com	China	89667	60
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	8000	62
BOC Sciences	16314854226; +8616314854226	inquiry@bocsci.com	United States	19852	58
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1577	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10305	58
Bide Pharmatech Ltd.	400-1647117 13681763483	product02@bidepharm.com	China	59929	58
TargetMol Chemicals Inc.	4008200310 15002144251	marketing@tsbiochem.com	China	24951	58
Biolab Reagents	027-65279366 18108604356	products@biolabreagent.com	China	9864	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	7283	58

Supplier	Advantage
Bide Pharmatech Ltd.	60
Shanghai YuanYe Biotechnology Co., Ltd.	60
ShangHai Biochempartner Co.,Ltd	62
BOC Sciences	58
Guangzhou Hongyuan Chemical Co.,Ltd	58
Wuhan Chemstan Biotechnology Co., Ltd.	58
Bide Pharmatech Ltd.	58
TargetMol Chemicals Inc.	58
Biolab Reagents	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	58

915296-00-3(Elotuzumab)Related Search:

Uliledlimab Bavituximab Lucatumumab Fasinumab Sutimlimab

Cofetuzumab Urtoxazumab Simtuzumab Aprutumab Cusatuzumab

1of2

Elotuzumab Research Grade Elotuzumab(DHJ64001) Elotuzumab (anti-SLAMF7) Elotuzumab (anti-SLAMF7)|||BMS 901608|||PDL 063|||HuLuc 63 Research Grade Elotuzumab 915296-00-3